Gara Jalqabaatti › Dhibee Onneessaa fi Dhiiga › Oklahoma
Qorannoo klinikaalii Dhibee Onneessaa fi Dhiiga Oklahoma keessatti
Qorannoo 11 Dhibee Onneessaa fi Dhiiga f Oklahoma keessatti hirmaatuu jiru.
Magaalota Oklahoma keessatti
Takkalaa qorannoo (Ingiliffa)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- South Oklahoma Heart Research, LLC, Oklahoma City
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06909565A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Oklahoma Heart Institute, Tulsa
Namoota walitti qabaa jira
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07214376EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Tekton Research Oklahoma City, Oklahoma City
- South Oklahoma Heart Research Group, Oklahoma City
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07064473Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Edmond
- Clinical Trial Site, Moore
- Clinical Trial Site, Norman
- fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07181109Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- Integris Baptist Medical Center, Oklahoma City
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT03242642A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Oklahoma City
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Alliance for Multispecialty Research, Norman
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 50 hanga 105 · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT07136012Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Integris Baptist Medical Center, Oklahoma City
- Oklahoma Heart Institute at Utica, Tulsa
- Saint Francis Hospital, Tulsa
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT06526195The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Oklahoma Heart Institute Hospital, Tulsa
- Saint Francis Hospital,, Tulsa
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT03142152MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- University of Oklahoma Health Science Center, Oklahoma City
Namoota walitti qabaa jira
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 11-Ful-2025 · NCT06271590MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- Oklahoma University Health (OU Health), Oklahoma City
Namoota walitti qabaa jira
Umuriin 18 hanga 110 · Saalaa hunda · Haaromfame 25-Gur-2025 · NCT05908331Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.